Gail Lynn Shaw Wright

Florida Cancer Specialists & Research Institute — United States

Medicine · Health Sciences

6h-index268citations21works35.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(11), Advanced Breast Cancer Therapies(7), HER2/EGFR in Cancer Research(6), Colorectal Cancer Treatments and Studies(3), Prostate Cancer Diagnosis and Treatment(2)

Publications20 total

A phase II study of niraparib plus bevacizumab maintenance following frontline platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: Final analysis from the OVARIO study
Gynecologic Oncology·2025
H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive (ER+), HER2 negative (–) breast cancer (BC).
Journal of Clinical Oncology·2024· 4 cited
Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor + (HR+), HER2- metastatic breast cancer (MBC) not previously treated with a taxane.
Journal of Clinical Oncology·2021· 1 cited
Phase I/II study of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer.
Journal of Clinical Oncology·2021· 37 cited
Abstract PD8-06: Phase I/II trial of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer
Cancer Research·2021· 6 cited
Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine (HER2CLIMB).
Journal of Clinical Oncology·2020· 6 citedOpen Access
SOPHIA analysis by chemotherapy (Ctx) choice: A phase III (P3) study of margetuximab (M) + Ctx versus trastuzumab (T) + Ctx in patients (pts) with pretreated HER2+ metastatic (met) breast cancer (MBC).
Journal of Clinical Oncology·2020· 5 cited
Abstract OT1-08-07: CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxane
Cancer Research·2020
SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx).
Journal of Clinical Oncology·2019· 80 cited
A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer
Clinical Breast Cancer·2018· 7 cited
Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study
Clinical Breast Cancer·2018· 14 cited
Abstract PD5-11: Not presented
Cancer Research·2018
Abstract P4-22-04: A randomized, double-blind, phase 2 study of ruxolitinib (RUX) or placebo (PBO) in combination with capecitabine (CAPE) in patients (pts) with advanced HER2-negative breast cancer (ABC) and elevated C-reactive protein (CRP), a marker of systemic inflammation
Cancer Research·2017· 1 cited
Abstract OT1-03-15: The METRIC trial: A randomized international study of the antibody-drug conjugate glembatumumab vedotin (GV or CDX-011) in patients with metastatic gpNMB-overexpressing triple-negative breast cancer (TNBC)
Cancer Research·2016· 2 cited
Evaluation of a Penile Clamp to Improve Bladder Filling in Patients Undergoing Radiation Therapy for Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2015· 1 cited
Weekly <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (gem) or carboplatin (carbo) vs gem/carbo as first-line treatment for metastatic triple-negative breast cancer (mTNBC) in a phase 2/3 trial (tnAcity).
Journal of Clinical Oncology·2015· 1 cited
EP-1932: Iodine-125 seed prostate brachytherapy: seed prediction and class solutions
Radiotherapy and Oncology·2014
Safety and efficacy of electron beam radiation therapy for epithelial skin cancer in geriatric patients
Journal of Geriatric Oncology·2012
Technical aspects of irradiation therapy.
PubMed·1952
Middle Eastern district meeting at Philadelphia October 13–15
Journal of the A.I.E.E.·1930Open Access

Frequent Co-authors

Erika Hamilton(5), Hope S. Rugo(4), Timothy Pluard(4), Denise A. Yardley(4), Javier Cortés(3), Barbara Haley(3), Stephen Johnston(3), Aki Morikawa(3), Anne Armstrong(3), Pamela N. Münster(3), Fadi Kayali(3), Dejan Juric(3), DA Yardley(3), X. Cynthia(3), Joyce O’Shaughnessy(3), Seock‐Ah Im(2), Michelino De Laurentiis(2), Shakeela Bahadur(2), David Riseberg(2), Fátima Cardoso(2)